( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
105175.5
108927.8
102071.4
101983.2
Total Expenditure
91096.1
95049.3
88973.4
91374.4
PBIDT (Excl OI)
14079.4
13878.5
13098
10608.8
Other Income
1022.1
896.8
688.7
939.5
Operating Profit
15101.5
14775.3
13786.7
11548.3
Interest
1341.8
1408.3
1441.2
1498.1
Exceptional Items
-300.5
174.1
NA
-70.6
PBDT
13459.2
13541.1
12345.5
9979.60
Depreciation
2689
2619
2518.4
2412.3
Profit Before Tax
10770.2
10922.1
9827.10
7567.30
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
8225.2
8217.10
7283.20
6179.40
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
8225.2
8217.10
7283.20
6179.40
Minority Interest
10.1
-9.8
-5
10.3
Shares of Associates
52.6
-137.9
-136.6
-279.8
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
8287.9
8069.4
7141.6
5909.9
Equity Capital
1647.4
1647.4
1647.3
1647.3
Calculated EPS
10.06
9.79
8.67
7.17
Calculated EPS (Annualised)
40.24
39.18
34.68
28.70
No of Public Share Holdings
319638022
319632204
320451974
322238899
% of Public Share Holdings
38.77
38.77
38.9
39.12
PBIDTM% (Excl OI)
13.38
12.74
12.83
10.40
PBIDTM%
14.35
13.56
13.50
11.32
PBDTM%
12.79
12.43
12.09
9.78